investor conference

Zymeworks will present clinical and preclinical data at two major healthcare investor conferences in April, including the Needham Virtual Healthcare Conference and Bloom Burton & Co. event.

Plug Power executives to present at Roth Annual Growth Conference in March 2026, discussing company strategy and financial outlook with institutional investors.

PEDEVCO executives will present at the 38th Annual Roth Conference in March 2026, hosting investor meetings and showcasing updated strategic plans.

Endeavor Bancorp ($EDVR) to present at Banking Virtual Investor Conference March 26, 2026, following $10M capital raise and Q4 net income of $1.7M.

EnerCom announces 70+ companies presenting at its 31st annual Energy Investment Conference in Denver, August 2026, attracting 1,000+ institutional investors and professionals.

Honest Company confirms CFO and investor relations head will participate in March 2026 ROTH Conference investor meetings in Dana Point, California.

UFPT executives to participate in KeyBanc Capital Markets virtual healthcare forum on March 18, with scheduled investor meetings.

IRADIMED Corporation to present MRI-compatible medical device portfolio at prestigious Roth Conference in March 2026, with CEO and CFO meeting investors directly.

Hubbell CFO Joe Capozzoli will present at JP Morgan Industrials Conference March 18, 2026, with webcast available via investor relations website.

Aduro Clean Technologies to present investor updates on pilot operations and Hydrochemolytic™ technology commercialization at the March 2026 ROTH Conference in California.

Rezolute to present ersodetug antibody therapy program at Citizens Life Sciences Conference in Miami, March 10-11, 2026, with direct investor meetings.

Brunswick Corporation will present at the Raymond James Annual Investor Conference on March 3, 2026, with live webcast and 90-day replay access.

Nkarta to present at two major healthcare investor conferences in March 2026, showcasing updates on its engineered NK cell therapy pipeline for autoimmune diseases.

Dycom Industries to present at two major investor conferences in March 2026, including Cantor Global Technology & Industrial Growth and Jefferies Virtual Power x Data Center events.

MacroGenics to participate in four major healthcare investor conferences in March 2026, with management presenting on pipeline developments and business operations.

Nasdaq raised Solutions segment revenue guidance to 9-12% annual growth and will discuss strategic priorities at March 2026 investor conferences, emphasizing AI and compliance solutions.

Stella-Jones leadership will present at Raymond James conference March 4, 2026, discussing business performance and strategy through fireside chat and investor meetings.

Stella-Jones will present at Raymond James 2026 Institutional Investor Conference on March 4 in Orlando, with CEO and CFO discussing business developments and strategy.

Arlo Technologies to present at investor conferences, showcasing business strategy and performance. Presentations will be streamed live with replays available on its investor relations website.

Prime Medicine will present at three major biotech conferences in March 2026, including TD Cowen and Citizens Life Sciences, with webcasts available afterward.